Medindia

X

Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent

Monday, January 4, 2010 Research News J E 4
Advertisement
Company to contribute data to industry-sponsored Dual Antiplatelet Therapy (DAPT) Study

CONTACT:

Paul Donovan

508-650-8541 (office)

508-667-5165 (mobile)

Media Relations

Boston Scientific Corporation

Larry Neumann

508-650-8696 (office)

Investor Relations

Boston Scientific Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Milestone Scientific Extinguishes $1.3 Million in ...
S
Frost & Sullivan: Nanotechnology Holds Promise, bu...